Dachaigh › Lymphoma Cealla B Mòr Sgaoilte › Sgìre Cholumbia › Washington
Sgrùdaidhean clionaigeach Lymphoma Cealla B Mòr Sgaoilte ann an Washington, DC
Tha 12 sgrùdaidhean airson Lymphoma Cealla B Mòr Sgaoilte a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mìle air falbh
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A’ fastadhÌre 2
- MedStar Georgetown University Hospital, Washington D.C.
- The Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
A’ fastadhÌre 2
- Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
A’ fastadhÌre 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A’ fastadhÌre 3
- American Oncology Partners, P.A. ( Site 0185), Bethesda · 7 mìle air falbh
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A’ fastadhÌre 2
- Georgetown University Medical Center ( Site 0117), Washington D.C.
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
A’ fastadhÌre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
- Medstar Georgetown University Hospital, Washington D.C.
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
A’ fastadhÌre 1
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A’ fastadhÌre 3
- MedStar Georgetown University Hospital, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- National Institute of Health, Bethesda · 7 mìle air falbh
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Sgrùdaidhean Lymphoma Cealla B Mòr Sgaoilte ann am bailtean eile
- New York City, NY21 sgrùdaidhean
- Baldwin Park, CA19 sgrùdaidhean
- Chicago, IL18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Boston, MA16 sgrùdaidhean
- Nashville, TN15 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Portland, OR15 sgrùdaidhean
- Durham, NC14 sgrùdaidhean
- Dallas, TX13 sgrùdaidhean
Sgrùdaidhean eile ann an Washington
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag55 sgrùdaidhean
- Aillse a' bhroilleach46 sgrùdaidhean
- Ailse metastatach43 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Aillse Prostata38 sgrùdaidhean
- Obesity33 sgrùdaidhean
- Aillse colorectal29 sgrùdaidhean
- Galarachd Cardiovasculach28 sgrùdaidhean
- Aillse sa bhlaire26 sgrùdaidhean
- Leukemia myeloid geur24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.